MAIN


1996-2019. All Rights Reserved. Online Journal of Bioinformatics. You may not store these pages in any form except for your own personal use. All other usage or distribution is illegal under international copyright treaties. Permission to use any of these pages in any other way besides the before mentioned must be gained in writing from the publisher. This article is exclusively copyrighted in its entirety to OJB publications. This article may be copied once but may not be, reproduced or re-transmitted without the express permission of the editors. Linking: To link to this page or any pages linking to this page you must link directly to this page only here rather than put up your own page.


OJBtm
Online Journal of Bioinformatics
Established 1995

ISSN  1443-2250


Volume
19(3):234-239, 2018.


Subtractive genomics for membrane drug targets for antibiotic resistant Chlamydia trachomatis A/HAR-13.

 

Vijayakumari SM1*, Shivkumar M1, Biplab B2, Keshava M2, Jhinuk C2

 

1Department of Bioinformatics,KSW University, Bijapur, India. 2Department of Biotechnology, PES Institute of technology, Bangalore,India .

 

ABSTRACT

 

Vijayakumari SM, Shivkumar M, Biplab B, Keshava M, Jhinuk C., Subtractive genomics for membrane drug targets for antibiotic resistant Chlamydia trachomatis A/HAR-13, Onl J Bioinform., 19(3):234-239, 2018. A subtractive genomics approach was employed to identify metabolic pathways-related candidate drug and vaccine targets in Chlamydia trachomatis virulent strain A/HAR-13. A filter for drug proteome based on pre-set conditions to generate a set of membrane associated human-non homologous drug targets was used. Survival and segregation of Chlamydia trachomatis unique metabolic pathway proteins and structure generation of the membrane associated drug targets was validated. Five membrane associated drug targets participating in peptidoglycan biosynthesis; cell cycle caulobacter & lipopolysaccharide biosynthesis were identified and their 3D structures generated & validated. These putative drug targets identified can be used as a platform for screening against a battery of anti-microbial leads. Computational analysis of the result indicates that out of 919 proteins of Chlamydia trachomatis A/HAR-13; 314 were found to be essential after subjecting the non-homologous sequence to blastp against the DEG database. The essential gene of Chlamydia trachomatisA/HAR-13 is listed and analyzed for cellular localization and biochemical metabolic pathway analysis. The list of proteins predicted to have unique pathway is given and drug targets having unique pathogenic specific pathways localized in membrane were considered for further analysis since membrane bound proteins are easier to target and as they are surface proteins they are exposed to immune system as can be used an epitopes for vaccine design. A list of putative drug targets with its predicted function, localization, and pathway is given.

 

Keywords: subtractive genomics, drug targets, Chlamydia.


MAIN

 

FULL-TEXT (SUBSCRIPTION OR PURCHASE ARTICLE $25USD)